Polyuria and nocturia in individuals with type 2 diabetes may be due to obstructive sleep apnea (OSA), a recently recognized etiology of excess nighttime urine production. This exploratory study examined the relationships among glucose control, OSA, and nocturnal urine production.
METHODS
A sample of community-dwelling older adults (20 nondiabetic subjects and 10 poorly controlled type 2 diabetes subjects) was recruited based on self-report of nocturia more than twice per night. Participants were monitored on a metabolic research unit for 24 hours to track intake/output, collect blood and urine samples, and conduct an overnight polysomnography sleep study.
RESULTS
None of the subjects had fasting serum glucose levels above the renal threshold. OSA was found in 65% of subjects. Those with moderate/severe OSA had significantly greater overnight urine production than subjects without OSA. Subjects with type 2 diabetes and moderate/severe OSA had the highest nocturnal urine production.
CONCLUSIONS
The high incidence of undetected OSA in subjects with type 2 diabetes with nocturia suggests that nocturia, OSA, and type 2 diabetes frequently coexist and may be interrelated.
Get full access to this article
View all access options for this article.
References
1.
1. Spira A, Gowirshankar M, Halperin M.Factors contributing to the degree of polyuria in: a patient with poorly controlled diabetes. Am J Kidney Dis.1997;30:829-835.
3. Maggi S, Langolis JA, Minicuci N, Grigoletto F, Pavan M, Foley DJ. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported cases. J Am Geriatr Soc.1998;46: 161-168.
4.
4. Barker J, Mittness L.Nocturia in the elderly. Gerontologist. 1988;28:99-104.
5.
5. Barry M, Abraham T, Cockett H, et al. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urology. 1993;150: 351-358.
6.
6. Chai TC, Belville WD, McGuire EJ, Nyquist L.Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urology. 1993; 150:1710-1713.
7.
7. Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D.Symptom status and quality of life following prostatectomy. JAMA. 1988; 259:3018-3022.
9. Holtgrewe H.American Urologic Association survey of transurethral prostectomy and the impact of changing medicare reimbursement. Urologic Clin North Am. 1990;17: 587-587.
10.
10. Nitti VW, Kim Y, Combs AJ. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urology. 1997;157:600-603.
11.
11. Peters TJ, Kay HE, et al. The International Continence Society Benign Prostatic Hyperplasia Study: the bothersomeness of urinary symptoms. J Urology. 1997; 157:885-889.
12.
12. Seaman EK, Jacobs BZ, Blaivas JG, Kaplan SA. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urology. 1994:152-152.
13.
13. Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostatic hyperplasia. J Urology. 1993;150:1706-1709.
14.
14. Asplund R, Aberg H.Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med.1991;229: 131-134.
15.
15. Saito M, Kondo A, Kato T, Yamada Y.Frequency-volume charts: comparison of frequency between elderly and adult patients. Br J Urology. 1993;72:38-41.
16.
16. Matthiesen T, Tittig S, Norgaard J, Pederson E, Djurhuus J.Nocturnal polyuria and naturesis in male patients with nocturia and lower urinary tract symptoms. J Urology. 1996;156:1291-1299.
17.
17. Guilleminault C.Clinical features and evaluation of obstructive sleep apnea. In: Kryger TR, Dement WC, eds. Principles and Practices of Sleep Medicine. Philadelphia: WB Saunders; 1994:667-677.
18.
18. Bliwise DL, Bliwise NG, Partinen M, Pursley AM, Dement WC. Sleep apnea and mortality in an aged cohort. Am J Public Health. 1988;78: 544-547.
19.
19. He J, Kryger MH, Zorick FJ, Conway W, Roth T.Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94: 9-14.
20.
20. Kales A, Cadieux RJ, Shaw LC, et al. Sleep apnea in hypertensive population. Lancet. 1988;2:1005-1008.
21.
21. Koskenvuo M, Kaprio J, Partinen H, Langinvanio H, Sarna S, Heikkila K.Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:89-95.
22.
22. Lavie PR, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 1984;108:373-376.
23.
23. Strohl KP, Boehm KD, Denko CW, Noval RD, Decker MJ. Biochemical morbidity in sleep apnea. ENT J. 1993;72: 34-41.
24.
24. Chasens E, Umlauf MG, Pillion D.Sleep disturbances, nocturia and diabetes in African-American community dwelling adults. Sleep. 2000; 23:A105-A105.
25.
25. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J.The effect of sleep apnea on plasma and urinary catecholamines. Sleep. 1995; 18:377-381.
26.
26. Dimsdale JE, Coy TV, Ancoli-Israel S, Mills J, Clausen J, Ziegler MG. Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest. 1997; 111:639-642.
27.
27. Carlton CE, Scardino PT. Initial evaluation, including history, physical examination, and urinalysis. In: Walsh PC, Gittes AD, Perlutter AD, Stamey TA, eds. Campbell's Urology. Philadelphia: WB Saunders; 1986:276-283.
28.
28. Smith ML, Niedermaier ON, Hardy SM, Decker MJ, Strohl KP. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Sys.1996;56: 184-190.
29.
29. Hedner J, Ejnell H, Sellgren J, Hedner T, Walling G.Is high and fluctuating muscle sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension?J Hypertens. 1988;6:S529-S531.
30.
30. Rechtschaffen A, Kales A.A manual for standardized terminology: techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service. Brain Research Institute; 1968.
31.
31. American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular disease. Circulation. 1999; 100:1132-1133.
32.
32. Kiley JP, Edelman N, Derderian S, Horner M, Littner M.Cardiopulmonary Disorders of Sleep. Wake-up America: A National Sleep Alert. Bethesda, Md: National Institute on Aging, 1994.
33.
33. Redline S, Strohl KP. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med.1998;19:1-19.
34.
34. Guilleminault C, Dement WC. Sleep apnea syndromes and related disorders. In: Williams RL, Karacan I, eds. Sleep Apnea Syndromes. New York: Wiley; 1978:120-131.
35.
35. Young T, Evans L, Finn L, Plata M.Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20:705-706.
36.
36. Anderson J, Maxwell D, Payne N, Slater J, Bloom S.Atrial natriuretic peptide: physiological release associated with natriuresis during negative pressure breathing in man. Clin Sci.1989;76:423-429.
37.
37. Krieger J, Follenius M, Brandenberger G.Diurnal and nocturnal diuresis in OSA. Am Rev Resp Dis.1992; 47: 497-498.
38.
38. Pressman M, Fiqueroa W, Kendrick-Mohamed J, Greenspon L, Peterson D.Nocturia: a rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med.1996;156: 545-550.
39.
39. Umlauf MG, Burgio KL, Shettar S, Pillion D.Nocturia and nocturnal urine production in obstructive sleep apnea. Appi Nurs Res.1997;10:198-201.
40.
40. Umlauf M, Kurtzer E, Valappil T, Burgio K, Pillion D, Goode P.Sleep-disordered breathing as a mechanism for nocturia: preliminary findings. Ostomy/Wound Manage. 1999; 45:52-60.
41.
41. Young T, Hutton R, Finn L, Badr S, Palta M.The gender bias in sleep apnea diagnosis: are women missing because they have different symptoms?Arch Intern Med.1996;156: 2445-2451.
42.
42. Dement W, Miles L, Carskadon M.White Paper on Sleep and Aging. J Am Geriatr Soc.1982;31:25-50.
